The consists of scientists, public-health experts and physicians, including one criticized for spreading COVID-19 misinformation, conspiracy theories.

After federal health officials made abrupt changes to US Covid-19 vaccine recommendations for pregnant women last month, there’s new confusion and uncertainty about who can get the shots — and some reports that patients were turned away when they tried to get vaccinated.

In recent years COVID shots joined flu shots as an annual offering at most neighborhood pharmacies. But the current administration has thrown that into uncertainty

GSK said on Friday the European Medicines Agency had accepted the drugmaker's application to expand the use of its respiratory syncytial virus (RSV) vaccine, Arexvy, to adults aged 18 and above. An expanded approval will help GSK better compete with rivals such as Merck's mRESVIA and Pfizer's Abrysvo after U.

HHS Secretary Robert F. Kennedy Jr. named eight new members to the CDC’s panel of outside vaccine experts Wednesday, two days after firing all 17 of its members.

Just two days after retiring the entirety of the US Centers for Disease Control and Prevention’s vaccine advisory panel, US Health and Human Services Secretary Robert F. Kennedy Jr. has appointed several prominent critics of the government’s Covid-19 response to that committee.

GSK said on Friday the European Medicines Agency had accepted the drugmaker's application to expand the use of its respiratory syncytial virus vaccine, Arexvy, to include adults from 18 years of age.

Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS Newswire / June 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.

On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their vaccine development program will end next year.

GSK has applied to the European Medicines Agency to expand use of its respiratory syncytial virus (RSV) vaccine to adults below the age of 50 who are at risk of the disease, the British drugmaker said on Friday.